Denmark said today, Saturday, that a person died while another was in a serious condition due to blood clots and brain hemorrhage after they received the AstraZeneca vaccine to prevent “Covid-19”.
The agency that runs public hospitals in Copenhagen said that the two, who are hospital workers, received the AstraZeneca vaccine less than 14 days before their illness.
The Danish Medicines Agency confirmed that it had received “two dangerous reports”, without going into further details. There were no details of when the two people fell ill.
Denmark, which stopped using the AstraZeneca vaccine on March 11th, was among more than 12 countries that temporarily stopped using the vaccine after reports of rare blood clots in the brain that prompted scientists and governments to speed up the search for any relationship between the vaccine and blood clots.
Last week, some countries, including Germany and France, backed away from the decision to suspend the use of the vaccine after an investigation into reports of blood clots conducted by the European Union’s Medicines Control Authority concluded that the benefits of the vaccine outweigh its risks.
Denmark, Sweden and Norway said on Friday that they need more time to decide whether to use the vaccine.
AstraZeneca, which developed the vaccine with the University of Oxford, said that a review of more than 17 million people who received doses in the European Union and Britain found no evidence of an increased risk of developing blood clots.